ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

ACR Convergence 2021

November 5-9, 2021. All Virtual.

View by Number View by Title View Sessions
View by Date
Jump to:  View All • a b c d e f g h i j k l m n o [p] q r s t u v w x y z
  • Abstract Number: 1114
    Pachymeningitis: The Mayo Clinic Experience
  • Abstract Number: 1236
    Pain in Patients with Rheumatoid Arthritis Who Did or Did Not Achieve Treatment Response Based on Improvement in Swollen Joints with Baricitinib Clinical Trials
  • Abstract Number: 0743
    Pain Interference, Fatigue, Physical Function as Outcome Measures in Adult Myositis: Updates on the Validation Process by the OMERACT Myositis Working Group
  • Abstract Number: 0379
    Pain Sensitivity in Axial Spondyloarthritis – Comparisons Between Patients and Controls, Women and Men, and Between Different Pain Groups
  • Abstract Number: 0718
    Pain Severity and Interference in Adult Autoimmune Inflammatory Myopathies
  • Abstract Number: 1192
    Palliative Care for the Rheumatologist: An Educational and Patient Care Intervention
  • Abstract Number: 1613
    Pandemic and Patients: Examining Health-Related Behaviors of Patients with Systemic Sclerosis During the COVID-19 Pandemic
  • Abstract Number: 1719
    Pandemic-Associated Complications in Pregnant Women with Rheumatic Diseases
  • Abstract Number: 1265
    Paradoxical Effect of Vitamin D on Bone Mineral Density in SLE
  • Abstract Number: 1649
    Parameters by FDG-PET/CT Are Useful for Predicting Spontaneous Regression in MTX Associated Lymphoproliferative Disorder
  • Abstract Number: 1373
    Paraoxonase-1: Potential Novel Marker of Disease Extent and Activity in Systemic Sclerosis
  • Abstract Number: 1792
    Participation in Psoriatic Arthritis (PART2) – a Cross-sectional Study of Work Impairment in Psoriatic Arthritis Patients in the Netherlands
  • Abstract Number: 1104
    Pathogenic UBA1 Variants in Japanese Patients with Relapsing Polychondritis
  • Abstract Number: 0555
    Pathway-Driven Drug Repositioning in Systemic Sclerosis from Omics Data
  • Abstract Number: 1634
    Patient Activation and Health Literacy in the Pediatric to Adult Transition in Juvenile Systemic Lupus Erythematosus: Patient and Health Care Team Perspectives
  • Abstract Number: 0254
    Patient and Disease-Level Factors Associated with Sustained Cessation of Medication for Disease Remission in Systemic Juvenile Idiopathic Arthritis
  • Abstract Number: 0317
    Patient and Physician Perspectives on EULAR Sjögren’s Syndrome Patient Reported Index (ESSPRI) and EULAR Sjögren’s Syndrome Disease Activity Index (ESSDAI): A Qualitative Interview Study
  • Abstract Number: 0629
    Patient and Physician Satisfaction with Telemedicine Utilization for Delivery of Care in Patients with SLE – A Single Centre Experience
  • Abstract Number: 1814
    Patient Characteristics and Clinical Features Associate with Health-Related Quality of Life in Bio-naïve Patients with Active Psoriatic Arthritis Through Week 24 of the DISCOVER-2 Study
  • Abstract Number: 0814
    Patient Characteristics, Efficacy, and Treatment Patterns of Tofacitinib Monotherapy in Patients with RA: Contextualization of Randomized Controlled Trial Results with Real-world Data
  • Abstract Number: 1924
    Patient Clustering Based on Multimorbidity Patterns Predicts Healthcare Utilization and Mortality in Rheumatoid Arthritis Within Independent Real-World Datasets
  • Abstract Number: 0359
    Patient Journey with Axial Spondyloarthritis: Critical Issues from the Patient Perspective. Results from the European Map of Axial Spondyloarthritis (EMAS)
  • Abstract Number: 1913
    Patient Perceptions of Telemedicine Use in Rheumatology Clinics During the COVID-19 Pandemic: An Analysis from the COVID-19 Global Rheumatology Alliance
  • Abstract Number: 1157
    Patient Perspective on the Non Medical Switch of Originator to Its Biosimilar in Inflammatory Arthritis Using a Social Media Survey
  • Abstract Number: 0668
    Patient Perspectives and Preferences Regarding Gout and Gout Management: Impact on Adherence
  • Abstract Number: 1277
    Patient Perspectives on Two Distinct Patterns of Type 2 SLE Symptoms
  • Abstract Number: 1161
    Patient Preferences for Hydroxychloroquine in Systemic Lupus (SLE)
  • Abstract Number: 1169
    Patient Preferences for Outcome Measures for a Pragmatic Knee Osteoarthritis (OA) Clinical Trial: Results of a Cross-Sectional Patient Survey That Included Racial/Ethnic Minorities
  • Abstract Number: 1418
    Patient Reported Outcomes on Quality of Life in Patients with Giant Cell Arteritis and Polymyalgia Rheumatica
  • Abstract Number: 1122
    Patient-perceived Solutions to the Treatment Barriers in Knee Osteoarthritis: A Qualitative Study from a Diverse Patient Group Including Racial/ethnic Minorities
  • Abstract Number: 0753
    Patient-Reported Burden of Adverse Drug Reactions Attributed to the Use of Adalimumab and Etanercept in Patients with Inflammatory Rheumatic Diseases
  • Abstract Number: 1624
    Patient-Reported Care Utilization, Socioeconomic Status, and Health Status Among Young Adults with JIA
  • Abstract Number: 0745
    Patient-reported Outcomes and Safety Measures in Patients with Rheumatic Diseases Who Switched from Reference or Other Biosimilar Etanercept to Biosimilar Etanercept GP2015 and in Biologic-naïve Patients Starting a Treatment with GP2015: 12-month Interim Analysis from a Real-world Study
  • Abstract Number: 1911
    Patient’s and Rheumatologist’s Perspectives on the Burden of Adverse Drug Reactions Attributed to Biologics: A Qualitative Study
  • Abstract Number: 1289
    Patients Enrolled in the Accelerating Medicines Partnership (AMP) RA/SLE Network with Isolated Renal Disease Report Minimal Quality of Life Impairment on PROMIS-29 Compared to Patients with Extrarenal Symptoms
  • Abstract Number: 0098
    Patients with Chronic Inflammatory Rheumatic Diseases Report a Lower Frequency of Infections Than Controls and They Protect Themselves Well Against SARS-CoV-2 Transmission
  • Abstract Number: 0103
    Patients with Inflammatory Rheumatic Diseases Are at Increased Risk of COVID-19 Related Hospitalization: Data from a Prospective Controlled Cohort Study
  • Abstract Number: 0764
    Patients with Juvenile Systemic Sclerosis Have a Distinct Pattern of Organ Involvement: Results from the Juvenile Systemic Sclerosis Inception Cohort
  • Abstract Number: 0710
    Patients with Recent Onset, Active Polymyositis (PM), Dermatomyositis (DM) and Antisynthetase Syndrome (ASS) Have Reduced Muscle Endurance but Not Reduced Muscle Strength Compared to Patients with Established, Low-active Disease
  • Abstract Number: 1163
    Patients’ Insights About Hydroxychloroquine, and Patient-Recommended Strategies to Target Nonadherence
  • Abstract Number: 0263
    Patterns of Medication Switching in Juvenile Idiopathic Arthritis: A Retrospective Analysis of a National Administrative Claims Database
  • Abstract Number: 0772
    Pediatric Craniofacial Scleroderma: Assessing Handheld 3D Stereophotogrammetric Imaging Feasibility and Reliability
  • Abstract Number: 1620
    Pediatric Onset (< 16 Years) Non-infectious Uveitis: Results from Spanish National Registry
  • Abstract Number: 1636
    Pediatric Rheumatologists’ Perspectives on Diagnosis, Treatment and Outcomes of Sjögren Syndrome in Children and Adolescents
  • Abstract Number: 0512
    Peficitinib and Filgotinib Inhibit Angiogenesis via Suppression of VEGF Production in Rheumatoid Arthritis Fibroblast-like Synoviocytes
  • Abstract Number: 0665
    Pegloticase Treatment for Uncontrolled Gout in Kidney Transplanted Patients: Results of an On-going Multicenter, Open-Label, Efficacy and Safety Study
  • Abstract Number: 1593
    Perceived Impact of the COVID-19 Pandemic on Physical Activity Among Adult Patients with Rheumatologic Disease
  • Abstract Number: 1604
    Perceptions About COVID-19 Vaccination Among Patients with Rheumatic Diseases Enrolled in a National Patient Registry
  • Abstract Number: 1843
    Perceptions and Concerns Regarding COVID-19 Vaccination in Patients with Systemic Sclerosis in the Scleroderma Patient-centered Intervention Network (SPIN) Cohort
  • Abstract Number: 0398
    Performance of ACR CRISS Score and Revised ACR CRISS Response in a Phase 3 Trial of Lenabasum in Diffuse Cutaneous Systemic Sclerosis (dcSSc) in Which Background Immunosuppressive Therapies (bIST) Were Allowed
  • Abstract Number: 0702
    Performance of Commercial Autoantibody Testing in Comparison to Recognized Gold Standards in Myositis Autoantibody Testing
  • Abstract Number: 0748
    Performance of Standardized Scores for Disease Assessment and Pain in Patients Withspondyloarthritis and Fibromyalgia
  • Abstract Number: 0349
    Performance of the 2019 EULAR/ACR Classification Criteria for Systemic Lupus Erythematosus in a Predominantly African American Cohort
  • Abstract Number: 0320
    Performance of the Clinical Trials ESSDAI (ClinTrialsESSDAI), an Adjusted ESSDAI Score, in Two Randomised Clinical Trials in Patients with Primary Sjögren’s Syndrome
  • Abstract Number: 0335
    Performances of Different Classification Criteria for Systemic Lupus Erythematosus in a Single Center Cohort from Turkey
  • Abstract Number: 0404
    Perifollicular Hypopigmentation in Systemic Sclerosis: Associations with Clinical Features and Internal Organ Involvement
  • Abstract Number: 1197
    Periodontal Status Before Diagnosis in Patients with Rheumatoid Arthritis Predicts Cumulative Disease Activity in Years After Treatment Inititation
  • Abstract Number: 1842
    Peripheral Blood Cell Gene Expression Profiling Predicts Response to Mycophenolate in Systemic Sclerosis Related Interstitial Lung Disease
  • Abstract Number: 0056
    Peripheral Blood Immune Cell Profiling in Psoriatic Arthritis: Comparison of Patients with Healthy Controls
  • Abstract Number: 0841
    Persistence on JAK Inhibitors in Daily Practice: Evaluation of the Rhadar-registry
  • Abstract Number: 0810
    Persistent Disease Activity Impairs Work Productivity and Non-work Activity in Recent Onset Rheumatoid Arthritis
  • Abstract Number: 1213
    Persisting Pain in Rheumatoid Arthritis – an Essential yet Underrated Challenge
  • Abstract Number: 1064
    Pharmacist-Led Multidisciplinary Approach to Opioid Tapering in a Private Rheumatology Practice: Patient Outcomes
  • Abstract Number: 0823
    Pharmacokinetic and Pharmacodynamic Evaluation of a Proposed Biosimilar MSB11456 versus Both the US-licensed and EU-approved Tocilizumab: Results of a Randomized, Double-blind, Parallel-group, Single-dose Trial in Healthy Adults
  • Abstract Number: 1700
    Pharmacokinetic Boosting to Enable Once-Daily Reduced Dose Tofacitinib
  • Abstract Number: 1567
    Pharmacokinetics and Pharmacodynamics of Anthocyanins After Oral Administration of Oral Tart Cherry Juice Concentrate to Gout Patients
  • Abstract Number: 0411
    Pharmacokinetics, Safety, and Efficacy of Subcutaneous Brodalumab for Systemic Sclerosis with Moderate-to-severe Skin Thickening: A Single-arm, Open-label, Multi-dose, Phase 1 Trial
  • Abstract Number: 1441
    Pharmacological Characterization of GLPG3667, a Selective TYK2 Inhibitor for Treatment of Inflammatory Diseases
  • Abstract Number: 1509
    Pharmacological Inhibition of MALT1 Reverses Activation-Induced Metabolic Reprogramming and Ameliorates Autoimmune Pathogenesis in Multiple Animal Models of Chronic Inflammation
  • Abstract Number: 0416
    Pharmacological Response of Rituximab Based on Dose Intensity in Maintenance Therapy of ANCA-Associated Vasculitis
  • Abstract Number: 1829
    Pharmacological Treatment of Enthesitis – A Systematic Review on the Efficacy of the Available Options
  • Abstract Number: 0185
    Phase 1 Study Results of GS-5718, an Oral IRAK4-Inhibitor: Pharmacodynamics of Single and Multiple Doses of GS-5718 in Healthy Subjects
  • Abstract Number: L05
    Phase 2 Study Results from a Randomized, Double-blind, Placebo-controlled, Dose-finding Study to Evaluate Efficacy and Safety of Tigulixostat, a Novel Non-purine Selective Xanthine Oxidase Inhibitor, in Gout Patients with Hyperuricemia
  • Abstract Number: 0184
    Phase III, Randomized Trial Comparing Clinical Outcomes Between Patients with Moderate-to-severe Chronic Plaque Psoriasis Receiving Adalimumab Reference Product (RP) Continuously versus Those Who Switched Between BI 695501 and Adalimumab RP
  • Abstract Number: 1579
    Phenome-Wide Association of Gout Risk Loci
  • Abstract Number: 1106
    Phenotypes and Genotypes of NLRP3-AID in Chinese Adult Patients
  • Abstract Number: 1665
    Physical Activity Moderates Inflammatory Gene Expression in Rheumatoid Arthritis
  • Abstract Number: 1033
    Physical Inactivity Among Adults with Specific Chronic Conditions, by Arthritis Status, 49 States and District of Columbia, Behavioral Risk Factor Surveillance System, 2019
  • Abstract Number: 1233
    Physician and Patient Reported Effectiveness Outcomes Are Similar in Tofacitinib and TNF Inhibitors in Rheumatoid Arthritis Patients: Data from a Rheumatoid Arthritis Registry in Canada
  • Abstract Number: 0824
    Physicians’ Reasons for Prescribing Janus Kinase Inhibitors (JAKi) in Patients with Rheumatoid Arthritis, and Associated Alignment Between Physicians and Patients in a Real-world Clinical Setting
  • Abstract Number: 1182
    Pilot Health Literacy Curriculum Addressing Skills and Content Knowledge for Adult and Pediatric Rheumatology Fellows
  • Abstract Number: 1209
    Plasma Calprotectin as a Biomarker of Active Synovitis in Rheumatoid Arthritis: A Clinical and Ultrasound Study in Patients Treated with Il6 and JAK Inhibitors
  • Abstract Number: 1247
    Plasma Cell-free DNA Is a Useful Biomarker for Tocilizumab Therapy in Rheumatoid Arthritis
  • Abstract Number: 0461
    Plasmablast-derived Autoantibodies from Individuals At-risk for RA That Target RA-relevant Antigens Are Polyreactive with Arthritogenic Bacteria
  • Abstract Number: 1498
    Platelet Secreted LGALS3BP Induces a Pro-inflammatory Phenotype in Systemic Lupus Erythematosus
  • Abstract Number: 1172
    Podcast-Based Learning, a Valuable Tool for Learning Rheumatology
  • Abstract Number: 1653
    Positron Emission Tomography-Detected Uptake of 18F-Fluorodeoxyglucose in Visceral and Subcutaneous Adipose Tissue Is Associated with Articular Disease Activity and Arterial Inflammation in Rheumatoid Arthritis
  • Abstract Number: 0618
    Post-acute Sequelae of SARS-CoV-2 and Serological Response in a Cohort of Patients with Rheumatic Diseases
  • Abstract Number: 0419
    Post-induction ANCA Titer Does Not Predict Mortality or Renal Outcomes: A Target Trial Emulation Study
  • Abstract Number: 1943
    Post-inflammatory and Degenerative Changes in Patients with Psoriatic Arthritis and Axial Manifestations: Post-hoc Analysis from a Double-blind, Randomized, Phase 3b Trial
  • Abstract Number: 0777
    Potential Biomarkers of Cognitive Impairment in the Context of Childhood-Onset Systemic Lupus Erythematosus
  • Abstract Number: 1547
    Potential Predictors of Outcome for Anakinra Treatment in COVID-19 Patients with Macrophage Activation Syndrome
  • Abstract Number: 1522
    Potential Predictors of Persistence in Immune Check Point Inhibitor Induced Arthritis
  • Abstract Number: 1559
    Potential Predictors of Requirement for Mechanical Ventilation in Cases of COVID-19 Related Multisystem Inflammatory Syndrome in Children (MIS-C): Results of a Hospital-based Cohort Study from South India
  • Abstract Number: 0768
    Poverty and Length of Stay in Children Hospitalized with Pediatric Systemic Lupus Erythematosus: An Analysis of the 2016 Kids’ Inpatient Database
  • Abstract Number: 1745
    Pre-pregnancy Switching from Mycophenolate to Azathioprine in Patients with Lupus Nephritis: A Retrospective Outcome Analysis
  • Abstract Number: 1015
    Preclinical Investigation of the First-in-Class SIK2/SIK3 Inhibitor GLPG3970 in Models of Arthritis
  • Abstract Number: 0518
    Predicted Expression of Genes Involved in the Thiopurine Metabolic Pathway Is Associated with Azathioprine Discontinuation Due to Bone Marrow Toxicity
  • Abstract Number: 1729
    Predicting Adverse Pregnancy Outcomes in Women with Systemic Lupus Erythematosus (SLE) Using 2nd Trimester Estimated Glomerular Filtration Rate (eGFR)
  • Abstract Number: 1268
    Predicting Adverse Pregnancy Outcomes in Women with Systemic Lupus Erythematosus: A Comparison of Machine Learning Methods
  • Abstract Number: 1200
    Predicting Progression to RA in Patients with Seropositive Arthralgia
  • Abstract Number: 1228
    Predicting RA Remission with Subcutaneous Abatacept Treatment in the Real-world Setting
  • Abstract Number: 0076
    Predicting the Transitions Between Lupus Anticoagulant Status and Thrombosis in SLE Using a Multi-state Markov Model
  • Abstract Number: 0579
    Predicting Treatment Change in Rheumatoid Arthritis Patients Treated with TNF Inhibitors as First-Line Biologic Agent
  • Abstract Number: 1212
    Prediction of 1-Year Intravenous Abatacept Retention in Patients with RA Using Novel Machine Learning Techniques: Directionality and Importance of Predictors
  • Abstract Number: 1383
    Prediction of Digital Ulcers in Patients with Systemic Sclerosis Based on the Use of Platelet Inhibitors and Other Parameters – A EUSTAR Study on Derivation and Validation of a Clinical Prediction Model
  • Abstract Number: 1789
    Prediction of Psoriatic Arthritis in Patients with Psoriasis Using DNA Methylation Profiles
  • Abstract Number: 0388
    Prediction Tool for Damage Accrual Trajectory in Incident Systemic Sclerosis
  • Abstract Number: 1631
    Predictive Factors for Lack of Response to Treatment in a Long-term Cohort of Patients with Juvenile Idiopathic Arthritis-associated Uveitis
  • Abstract Number: 1314
    Predictive Factors for the Development Acute Anterior Uveitis Attacks in Patients with Axial Spondyloarthritis; The Results of a Longitudinal Analysis
  • Abstract Number: 1348
    Predictors for Achievement of Low Disease Activity at Week 56 in Patients with Psoriatic Arthritis Who Received Upadacitinib 15 Mg Once Daily: Pooled Analysis of Two Phase 3 Studies
  • Abstract Number: 0387
    Predictors for Progressive Fibrosis in Patients with Connective Tissue Disease Associated Interstitial Lung Diseases
  • Abstract Number: 0926
    Predictors of 1-Year Treatment Response Among Upadacitinib-Treated Patients with Ankylosing Spondylitis: A Post Hoc Analysis
  • Abstract Number: 1294
    Predictors of BILAG-based Outcomes in Patients with SLE: Analysis from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort and MASTERPLANS Consortium
  • Abstract Number: 1205
    Predictors of Discordance Between Patient and Physician Global Assessment in Patients with Rheumatoid Arthritis
  • Abstract Number: 1143
    Predictors of Engagement in Bone Health Care Among Rural Veterans at Risk for Osteoporosis
  • Abstract Number: 0585
    Predictors of Health-Related Quality of Life in Rheumatoid Arthritis Patients
  • Abstract Number: 0413
    Predictors of ILD Development and Timing of Onset in Systemic Sclerosis: A Canadian Cohort
  • Abstract Number: 0779
    Predictors of Mortality in a Series of 1528 Brazilian Childhood-onset Systemic Lupus Erythematosus Patients
  • Abstract Number: 0683
    Predictors of Rapidly Progressive Interstitial Lung Disease and Mortality in Patients with Autoantibodies Against Melanoma Differentiation-Associated Protein 5 Dermatomyositis
  • Abstract Number: 1410
    Predictors of Relapse in Giant-Cell Arteritis: A Retrospective Single Center Analysis
  • Abstract Number: 1276
    Predictors of Remission (on and off Treatment) and Lupus Low Disease Activity State (LLDAS) in Systemic Lupus Erythematosus (SLE): Data from a Multinational, Multicenter SLICC (Systemic Lupus International Collaborating Clinics) Cohort
  • Abstract Number: 1831
    Predictors of Response, Adverse Events and Treatment Retention in Psoriatic Arthritis Patients Treated with Golimumab in a Prospective, Observational Registry
  • Abstract Number: 1237
    Predictors of Response: Baseline Characteristics and Early Treatment Responses Associated with Achievement of Remission and Low Disease Activity Among Upadacitinib-Treated Patients with Rheumatoid Arthritis
  • Abstract Number: 0439
    Predictors of Rheumatic Immune-related Adverse Events and de Novo Inflammatory Arthritis After Immune Checkpoint Inhibitor-treatment for Cancer
  • Abstract Number: 0838
    Predictors of Treatment for Inflammatory Arthritis with Immune Modulating Medications (IMM) in US Veterans
  • Abstract Number: 1155
    Pregnancy Experiences and Unmet Needs for Women of Childbearing Age with Chronic Rheumatic Disease in China
  • Abstract Number: 0070
    Pregnancy Outcomes of Antiphospholipid Antibody Positive Patients: Prospective Results from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (“Registry”)
  • Abstract Number: 0499
    Preliminary Assessment of Internal Reliability and Construct Validity of Long and Short-form Assessment of Systemic Sclerosis-associated RAynaud’s Phenomenon (ASRAP) Questionnaires
  • Abstract Number: 1541
    Preliminary Criteria for Macrophage Activation Syndrome Associated with Coronavirus Disease-19
  • Abstract Number: 1614
    Preliminary Results from a Pilot Feasibility and Acceptability Trial of Resilience Coaching for Adolescent Chronic Musculoskeletal Pain
  • Abstract Number: 1378
    Presence of Anti-RNA Polymerase 3 Antibody in Systemic Sclerosis, Renal Disease, Malignancy and ILD from a Single Academic Center Cohort
  • Abstract Number: 1841
    Presence of Autoantibodies to Dense-Fine-Speckled 70 (DFS70) Do Not Necessarily Rule out Connective Tissue Diseases
  • Abstract Number: 0574
    Prevalence and Early Progression of Lung Diseases in Patients with Recently-Diagnosed Rheumatoid Arthritis: A Prospective Cohort Study
  • Abstract Number: 1785
    Prevalence and Incidence of PsA in Germany – a Cohort Study with 65 Million Participants
  • Abstract Number: 0290
    Prevalence and Predictors of Mortality in Rheumatoid Arthritis-Related Lung Disease: Results from a Single Center Study
  • Abstract Number: 0642
    Prevalence and Risk Factors for Cardio-metabolic Abnormalities in Patients with Inflammatory Arthritis Attending Cardio-rheumatology Primary Prevention Clinics
  • Abstract Number: 0862
    Prevalence and Risk Factors for Herpes Zoster Reactivation in 1542 Patients with Rheumatic Diseases
  • Abstract Number: 1148
    Prevalence and Risk Factors of Insufficiency Fractures of the Foot and Ankle Joint in Rheumatic and Musculoskeletal Diseases
  • Abstract Number: 0843
    Prevalence and Trends of Infections in Hospitalized Patients with Rheumatoid Arthritis in the United States
  • Abstract Number: 1145
    Prevalence of and Risk Factors for Vertebral Fractures and Low Bone Mass Density Among Women Aging with HIV in Peru
  • Abstract Number: 1517
    Prevalence of Autoantibodies in Patients with Melanoma Who Develop Rheumatic Immune Related Adverse Events During Treatment with Immune Checkpoint Blockade
  • Abstract Number: 0126
    Prevalence of Dyslipidemia in Fibromyalgia: A Single Center Case Control Study from South India
  • Abstract Number: 1043
    Prevalence of Multimorbidity in Cutaneous Lupus Erythematosus: A Population-Based Study
  • Abstract Number: 1561
    Prevalence of SARS-CoV2 Infection in Diseases Inflammatory Rheumatology in the Rheumatology Service of the Hospital Docente Padre Billini, Dominican Republic
  • Abstract Number: 0225
    Prevalence of Sexual Dysfunction and Depression in German Patients with Psoriasis and Psoriatic Arthritis – Results of the PIPPA Study
  • Abstract Number: 0332
    Prevalence of Systemic Lupus Erythematosus in the United States: Updated Population Representative Estimates from the Medical Expenditure Panel Survey (MEPS) 2016-2018
  • Abstract Number: 0412
    Prevalence, Distribution, Clinical Correlates and Outcomes of Upper Extremity Macrovascular Disease in Systemic Sclerosis: Results from a Single Center Referral Cohort (2001-2018)
  • Abstract Number: 0064
    Prevalence, Incidence and Predictor Features of Uveitis in Spondyloarthritis in a Canadian Cohort
  • Abstract Number: 0734
    Primary Total Knee Arthroplasty for Knee Osteoarthritis Among Younger versus Older Individuals: Cross-sectional Study of Surgical Appropriateness and Surgeon Decision-Making
  • Abstract Number: 0677
    Pro-Inflammatory Diet and Increased Risk of Incident Female Gout: 30-Year Prospective Cohort Study of >170,000 Pre- and Post-Menopausal US Women
  • Abstract Number: 0666
    Process Mapping Gout Hospitalizations: A Deep Dive into an Avoidable Epidemic
  • Abstract Number: 0312
    Prognostic Value of Salivary Gland Ultrasonography in Primary Sjögren’s Syndrome
  • Abstract Number: 1515
    Programmed Cell Death Protein 1 (PD-1)-Expressing CD4+ T Cells Are Expanded in Early Rheumatoid Arthritis and Correlate with Response to Treatment
  • Abstract Number: 0314
    PROMIS Provides a Broad Overview of Health-Related Quality of Life in the Evaluation of Sjogren’s Syndrome
  • Abstract Number: 1892
    Promotion of Autoimmune Arthritis via Tryptophan Metabolism and Production of the Bacterial-Derived Tryptophan Metabolite Indole
  • Abstract Number: 0248
    Proportion of Patients with a Polyphasic Disease Course in Systemic-onset Juvenile Idiopathic Arthritis May Be Higher in the Age of Cytokine Inhibitors
  • Abstract Number: 0434
    Protein Profiling in Pre-dating Samples Separate MPO-ANCA Vasculitis from PR3-ANCA Vasculitis
  • Abstract Number: 0961
    Proteomic Profiling of MIS-C Patients Reveals Heterogeneity Relating to Interferon Gamma Dysregulation and Vascular Endothelial Dysfunction
  • Abstract Number: 1010
    Proton Pump Inhibitors Suppress IL-1 Mediated Carditis in a Murine Model of Kawasaki Disease
  • Abstract Number: 0631
    Provider Assessment of Telehealth Utility During COVID-19
  • Abstract Number: 1715
    Providing High Quality Family Care Planning for Women with Rheumatic Disease in Rheumatology Clinics: Perspectives of Rheumatology Clinicians
  • Abstract Number: 1791
    Psoriasis Onset Before Rheumatic Symptoms in Patients with Spondyloarthritis: Does It Relate to Clinical Characteristics and the Rheumatologist’s Diagnosis? Data from REGISPONSER Registry
  • Abstract Number: 0241
    Psoriasis Rate Is Increased by the Exposure to TNF Inhibition in Children with JIA
  • Abstract Number: 1355
    Psoriatic Arthritis Incidence Among Patients Receiving Biologic Medications for Psoriasis; A Nested Case Control Study
  • Abstract Number: 0046
    Psoriatic Arthritis Skin Is Transcriptionally Different to Psoriasis Skin and Enriched in Immunoglobulin Transcripts
  • Abstract Number: 1827
    Psoriatic Arthritis, Female Sex and Increased Baseline Skin Severity Are Associated with Drug Persistence in Ustekinumab-Treated Patients with Psoriasis in the BADBIR Cohort
  • Abstract Number: 0846
    Psychometric Evaluation and Measurement Invariance of English and French Versions of the UCLA Loneliness Scale in Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network Cohort Study
  • Abstract Number: 0267
    Psychosocial and Health Measures in Systemic Lupus Erythematosus: Before and During the COVID-19 Pandemic in the Georgian’s Organized Against Lupus Cohort
  • Abstract Number: 0797
    Psychosocial Wellbeing and Illness Perceptions During the Early Disease Phase Predict Sustained Remission in Rheumatoid Arthritis
  • Abstract Number: 1100
    Pulmonary Arterial Hypertension in Adult-Onset Still’s Disease: A Case Series of 13 Patients
  • Abstract Number: 0276
    Pulse Pressure as a Predictor of Carotid Plaque in Rheumatoid Arthritis Patients
  • Abstract Number: 1503
    Putting the Pieces on the Board: Mapping SLE Nephritis Biopsies from the Accelerating Medicines Project Using High-Density Immunofluorescence Imaging
Jump to:  View All • a b c d e f g h i j k l m n o [p] q r s t u v w x y z
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences